Company intelligence / Profile preview

JQC (Huayin) Pharmaceutical

Huayin, Shaanxi, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

JQC (Huayin) Pharmaceutical is a leading manufacturer of salicylic acid series APIs and intermediates. Their products, such as aspirin, have longstanding global regulatory acceptance; their quality system is GMP certified and passed US FDA inspection. The company is preparing submissions for DMF, COS, REACH in major international markets, with 75% of revenue from overseas sales[1][3][10].

Therapeutic areas: ImmunologyNeurologyCardiovascularOther
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on JQC (Huayin) Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JQC (Huayin) Pharmaceutical.

Explore the full profile